BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 16785810)

  • 1. Esophageal diverticulum presenting as metastatic thyroid mass on iodine-131 scintigraphy.
    Rashid K; Johns W; Chasse K; Walker M; Gupta SM
    Clin Nucl Med; 2006 Jul; 31(7):405-8. PubMed ID: 16785810
    [No Abstract]   [Full Text] [Related]  

  • 2. Epiphrenic diverticulum: potential pitfall in thyroid cancer iodine-131 scintigraphy.
    Nguyen BD; Roarke MC
    Clin Nucl Med; 2005 Sep; 30(9):631-2. PubMed ID: 16100490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diffuse sclerosing variant of papillary thyroid carcinoma].
    Manrique Franco K; Domínguez Fernández R; Lara Capellán JI; Renedo Pascual G; Rovira Loscos A
    Endocrinol Nutr; 2010 Dec; 57(10):500-2. PubMed ID: 20843752
    [No Abstract]   [Full Text] [Related]  

  • 4. Accumulation of (131)INa activity in renal cysts unrelated to metastatic disease in a patient with differentiated thyroid cancer.
    Castillo-Berrio C; Zelaya F; Loira F; Castrillón M; López A; Outomuro J
    Rev Esp Med Nucl Imagen Mol; 2016; 35(1):70-1. PubMed ID: 26144698
    [No Abstract]   [Full Text] [Related]  

  • 5. Iodine-131 uptake in focal bronchiectasis mimicking metastatic thyroid cancer.
    Song HC; Heo YJ; Kim SM; Bom HS
    Clin Nucl Med; 2003 Apr; 28(4):351-2. PubMed ID: 12642729
    [No Abstract]   [Full Text] [Related]  

  • 6. Exercise-induced radio-iodine accumulation in scalp and hair during admission of 131I therapy for thyroid cancer.
    Zakavi SR; Kakhki VD
    Thyroid; 2006 Nov; 16(11):1185-6. PubMed ID: 17123349
    [No Abstract]   [Full Text] [Related]  

  • 7. Retention of iodine-131 in a thoracic esophageal diverticulum mimicking metastatic thyroid cancer.
    Song HC; Kim SM; Heo YJ; Bom HS
    Clin Nucl Med; 2002 Dec; 27(12):896-7. PubMed ID: 12607875
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidental finding of hiatal hernia on (99m)Tc-sestamibi whole-body scan in thyroid cancer evaluation.
    Del Castillo-Matos R; Quirce R; Martínez-Rodríguez I; Medina-Quiroz P; Rubio-Vassallo A; Carril JM
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):163-4. PubMed ID: 22056002
    [No Abstract]   [Full Text] [Related]  

  • 9. Retention of iodine-131 in respiratory tract in a patient with papillary thyroid carcinoma after radionuclide therapy: a rare false-positive finding.
    Kienast O; Hofmann M; Ozer S; Dobrozemsky G; Dudczak R; Kurtaran A
    Thyroid; 2003 May; 13(5):509-10. PubMed ID: 12855020
    [No Abstract]   [Full Text] [Related]  

  • 10. Metastatic parotid tumor: a rare presentation for papillary carcinoma of thyroid.
    Malhotra G; Nair N; Awasare S; Baghel NS
    Clin Nucl Med; 2007 Jun; 32(6):488-90. PubMed ID: 17515766
    [No Abstract]   [Full Text] [Related]  

  • 11. False positive uptake in post-treatment iodine-131 whole-body scans secondary to contamination.
    Schlosser J; Paliou M; Bravo-Vera R; Sheikh A; Gouller A
    Thyroid; 2007 Jan; 17(1):81-2. PubMed ID: 17274756
    [No Abstract]   [Full Text] [Related]  

  • 12. An interesting contamination artifact appearing in I-(131) whole-body imaging after ablative therapy.
    Ozcan Kara P; Sari O; Gedik GK; Kocak I; Kaya B
    Rev Esp Med Nucl; 2011; 30(1):36-7. PubMed ID: 21211869
    [No Abstract]   [Full Text] [Related]  

  • 13. False-positive findings on (131)I whole-body scans because of posttraumatic superficial scabs.
    Regalbuto C; Buscema M; Arena S; Vigneri R; Squatrito S; Pezzino V
    J Nucl Med; 2002 Feb; 43(2):207-9. PubMed ID: 11850486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
    de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. False-positive uptake of I-131 in a laryngocele mimicking thyroid remnant after thyroidectomy for papillary thyroid carcinoma.
    Schmidt M; Dietlein M; Schröder U; Schicha H
    Clin Nucl Med; 2006 Nov; 31(11):716-7. PubMed ID: 17053394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
    Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
    J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 99mTc-methoxyisobutyl isonitrile and 201Tl scintigraphy for detection of residual thyroid cancer after 131I ablative therapy.
    Seabold JE; Gurll N; Schurrer ME; Aktay R; Kirchner PT
    J Nucl Med; 1999 Sep; 40(9):1434-40. PubMed ID: 10492361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for the use of radio-iodine, thyroid hormone, and treatment of metastatic disease in patients with differentiated thyroid cancer.
    Paloyan E; Walker RP; Lawrence AM
    Surg Oncol Clin N Am; 1998 Oct; 7(4):665-80. PubMed ID: 9735128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Patients treated for differentiated thyroid cancer with negative 131I whole-body scans and elevated thyroglobulin levels: a possible course].
    Gutiérrez Cardo AL; Rodríguez Rodríguez JR; Borrego Dorado I; Navarro González E; Tirado Hospital JL; Vázquez Albertino R
    Rev Esp Med Nucl; 2007; 26(3):138-45. PubMed ID: 17524307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Iodine scintigraphy of differentiated thyroid carcinoma].
    Nakata K; Tsukamoto E; Ito K; Kato C; Furudate M
    Rinsho Hoshasen; 1988 May; 33(5):589-90. PubMed ID: 3047462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.